Back

High-risk pe patients eligible for both large-bore mechanical thrombectomy and systemic thrombolysis: insights from the FLASH and FLAME Studies

29 August 2026 (08:27 - 08:39)
Organised by: Logo
Congress Presentation Part of: Acute pulmonary embolism: risk and interventional therapies Pulmonary Embolism (PE) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lukas Hobohm

University Medical Center of Mainz, Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
Activated factor XI is associated with recurrent venous thromboembolism in patients following pulmonary embolism: a cohort study
Mr P. Michel (Krakow, PL)
Abstract Slides
Presentation thumbnail
Patients with pulmonary embolism and cardiogenic shock benefit from interventional therapy rather than conventional thrombolytic therapy. A case analysis of all inpatients in Germany 2022 and 2025
Doctor S. Lange (Munster, DE)
Abstract Slides
Presentation thumbnail
Early respiratory–metabolic phenotypes predict 48-hour hemodynamic deterioration in intermediate-high risk pulmonary embolism
Doctor M. Zuin (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Catheter-directed therapy in intermediate-high risk pulmonary embolism: which predictive factors for a favorable therapy response?
Doctor E. Blachere (Montpellier, FR)
Abstract Slides

Access the full session

Session thumbnail
Acute pulmonary embolism: risk and interventional therapies
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:27 CET
You may be interested in
thumbnail
Congress Presentation
Design and rationale of the PERSEVERE study: a randomized controlled trial of large-bore mechanical thrombectomy versus the standard of care for high-risk pulmonary embolism
30 August 2025
thumbnail
Congress Presentation
Parameters of treadmill exercise test and sympathetic activation are linked to the development of hypertension in subjects with high normal blood pressure
27 August 2021
thumbnail
Congress Presentation
Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study
27 August 2021
thumbnail
Congress Presentation
Randomized controlled trial of mechanical thrombectomy with anticoagulation versus anticoagulation alone for acute intermediate-high risk PE: primary outcome and functional endpoints from STORM-PE
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources